Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • Guidance
  • News

Barnes Clocks ~1% Sales Growth In Q4 Amid Persistent Pressures In Industrial Segment

By Anusuya Lahiri
February 17, 9:30 AM
Barnes Group Inc (NYSE:B) reported fourth-quarter FY22 sales growth of 1% year-over-year at $313.5 million, +5% on an organic…

B

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • Guidance
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

HubSpot Gets Price Target Bumps By Analysts After Upbeat Q4 Results

By Lisa Levin
February 17, 8:57 AM
HubSpot Inc (NYSE: HUBS) reported better-than-expected Q4 results and issued strong guidance.

HUBS

Read More
1 minute read
  • Buybacks
  • Dividends
  • Earnings
  • Guidance
  • News

AdvanSix Registers 5% Sales Decline In Q4 Due To Softness In End Market Demand

By Anusuya Lahiri
February 17, 8:41 AM
AdvanSix Inc (NYSE: ASIX) reported a fourth-quarter FY22 sales decline of 5% year-over-year to $404.06 million, missing the consensus of $472.6…

ASIX

Read More
2 minute read
  • Earnings
  • Guidance
  • News

Stryve Foods, Inc. Pre-Announces Select Q4 And FY22 Metrics; Expects FY22 Net Sales $29M-$32M

By Happy Mohamed
February 17, 1:28 AM
Net Sales, Gross Margins and Operating Expenses on Track Consumption Numbers up 27% on 52-week Data Stryve Nutrition Portfolio Exited as Part of Rationalization PLANO, Texas, Feb. 16, 2023 (GLOBE NEWSWIRE)

SNAX

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News

Pool Corp Clocks 6% Sales Growth In Q4; Notes Margin Pressure

By Shivani Kumaresan
February 16, 2:56 PM
Pool Corp (NASDAQ:POOL) reported fourth-quarter FY22 sales growth of 6% year-on-year to $1.09 billion, missing the consensus of $1.15 billion. Base…

POOL

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Guidance
  • Management
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics
  • Startups
  • Top Stories

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation

By Lara Goldstein
February 16, 2:52 PM
Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug development pipeline.

PSYCF

Read More
2 minute read
  • Cannabis
  • General
  • Global
  • Guidance
  • Health Care
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose

By Lara Goldstein
February 16, 2:38 PM
Algernon Pharmaceuticals (OTCQB: AGNPF)’s subsidiary Algernon NeuroScience has completed the first cohort in its Phase 1 clinical study of

AGNPF

Read More
1 minute read
  • Buybacks
  • Dividends
  • Earnings
  • General
  • Guidance
  • News

Bloomin’ Brands Q4 Bottom-Line Exceeds Expectations; Hikes Dividend By 71%; Plans Stock Buyback

By Shivani Kumaresan
February 16, 2:36 PM
Bloomin’ Brands Inc (NASDAQ:BLMN) reported fourth-quarter FY22 sales growth of 4.6% year-on-year to $1.09 billion, missing the consensus of $1.12 billion.…

BLMN

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News

US Foods Clocks 11.5% Sales Growth In Q4; Bottom-Line Beats Street View

By Shivani Kumaresan
February 16, 1:59 PM
US Foods Holdings Corp (NYSE:USFD) reported fourth-quarter FY22 sales growth of 11.5% year-on-year to $8.52 billion, missing the consensus of $8.53…

USFD

Read More
1 minute read
  • Guidance
  • Management
  • News

SNAP Says “In Q4, Total Time Spent Watching Spotlight More Than Doubled YoY; And Spotlight Submissions Went Up Nearly 20% Over The Same Time Frame”

By Happy Mohamed
February 16, 1:52 PM
- Investor Day

SNAP

Posts pagination

Previous 1 … 488 489 490 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service